| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/26/2008 | US20080154242 Delivery device for a fluid |
| 06/26/2008 | US20080154241 Latent stabilization of bioactive agents releasable from implantable medical articles |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080153915 Pharmaceutical Preparation For the Oral Cavity |
| 06/26/2008 | US20080153900 Administering an anti-microtubule agent such as campothecin, eleutherobin, sarcodictyins, epothilones, discodermolide, deuterium oxide, hexylene glycol, tubercidin or a taxane to treat diseases including psoriasis, arthritis, stenosis, graft rejection, vasculitis and inflammatory lung diseases |
| 06/26/2008 | US20080153879 Method of managing or treating pain |
| 06/26/2008 | US20080153739 Compositions and methods for treatment of hyperplasia |
| 06/26/2008 | US20080153738 Compositions and methods for treatment of hyperplasia |
| 06/26/2008 | US20080153694 Amorphous Silica Particles Having High Absorbing Capabilities and High Structural Characteristics |
| 06/26/2008 | US20080153166 Stable lipid-comprising drug delivery complexes and methods for their production |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080152894 Treated substrates having improved delivery of impregnated ingredients |
| 06/26/2008 | US20080152738 Oil-in-water emulsions; agglutination; evaporation; lectin |
| 06/26/2008 | US20080152720 Nanoparticulate tacrolimus formulations |
| 06/26/2008 | US20080152719 Multiparticulate Pharmaceutical Form Comprising Pellets With a Matrix Which Influences the Delivery of a Modulatory Substance |
| 06/26/2008 | US20080152718 Bi-layer core isradipine; sustained release |
| 06/26/2008 | US20080152717 Enhanced bioavailability; solvent spray drying |
| 06/26/2008 | US20080152716 Sustained release of isradipine |
| 06/26/2008 | US20080152715 Dissolving the vitamin K and terpolymer in ethanol; spraying into a reactor containing supercritical carbon dioxide; desolventization; recovering the nanospheres; antiscarring agents; skin disorders; stetch marks |
| 06/26/2008 | US20080152714 Pharmaceutical Formulations |
| 06/26/2008 | US20080152713 Herbal Contraceptive Formulation |
| 06/26/2008 | US20080152712 N-[1-oxo-3-methyl-4-((3-(3-fluorophenyl)-pyridin-6-yl)ethenyl)naphtho[2,3-c]furan-7-yl]butanamide bisulfate; administerable to unconscious patients suffering from acute coronary syndrome |
| 06/26/2008 | US20080152711 Compressible solid particles, procedures for the obtention thereof and procedures for the use of said particles in body-cleansing tablets |
| 06/26/2008 | US20080152710 Co-beadlet of dha and rosemary and methods of use |
| 06/26/2008 | US20080152709 Clonidine composition and method of use |
| 06/26/2008 | US20080152708 Injectable, sucrose acetate isobutyrate solution easily formulated with therapeutic agents |
| 06/26/2008 | US20080152707 Solubilized CoQ-10 and Carnitine |
| 06/26/2008 | US20080152706 Wherein the dihydrolipoic acid acts as a reducing agent for the coenzyme Q10 and also, optionally, as a solvent; periodontal diseases, mitochondrial related diseases and disorders, Parkinson's disease, Prader-Willi syndrome, migraines |
| 06/26/2008 | US20080152705 Corosolic Acid Formulation and Its Application for Weight-Loss Management and Blood Sugar Balance |
| 06/26/2008 | US20080152704 Gelatin capsules filled with an aqueous dispersion of lipophilic components and surfactants; antiemitic agents for chemotherapy and radiotherapy patients |
| 06/26/2008 | US20080152703 Epitopes formed by non-covalent association of conjugates |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | US20080152701 Methods and Compositions for the Treatment and Prevention of Staphylococcus Infections |
| 06/26/2008 | US20080152700 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a c-Ha-ras gene and the second hybridizing to an oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 06/26/2008 | US20080152699 Method of treating menopausal women transdermally with testosterone |
| 06/26/2008 | US20080152696 Nutritional supplement for children from infants to adolescents; tablets, capsules or reconstitutable powders containing partially hydrolyzed recombinant leptin |
| 06/26/2008 | US20080152695 Oral/buccal transmucosal delivery methods for electrolyte compositions including xylitol |
| 06/26/2008 | US20080152694 Devices, Systems and Methods for Ophthalmic Drug Delivery |
| 06/26/2008 | US20080152690 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152686 Adding microscopic porosity to the surface of a microcoil to be used for medical implantation |
| 06/26/2008 | US20080152676 Device for delivering antidotes |
| 06/26/2008 | US20080152675 Sustained release of drug in an aqueous phase containing at least one amphiphilic polymer; dispersion in a continuous lipid phase; water in oil emulsions; low viscosity for injection; aspartate-glutamate or aspartic-glutamic copolymers; biodrugs |
| 06/26/2008 | US20080152674 Applying to body surface an epilation composition of semi-crystalline polymer having a first and second shear storage modulus, wherein first is less than the second; hair removal from skin |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152598 Oral composition for stabilization, (re)calcification and (re)mineralization of tooth enamel and dentine |
| 06/26/2008 | US20080152597 Dermal penetration enhancers and drug delivery systems involving the same |
| 06/26/2008 | US20080152596 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
| 06/26/2008 | US20080152595 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 06/26/2008 | US20080152585 comprising a mixture of drugs having nanostructure particle sizes, surfactants and excipients or carriers |
| 06/26/2008 | DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration |
| 06/26/2008 | DE102007036184A1 Composition, useful e.g. to reduce the formation of white residues on the cloth and skin, and as a thickener, emulsifier, thickener and stabilizer, comprises phosphoric acid ester, surfactant, electrolyte, hydrogen peroxide and water |
| 06/26/2008 | DE102006060938A1 Materialdepot zur Abgabe eines antibakteriellen Wirkstoffmaterials Material depot to submit an antibacterial agent material |
| 06/26/2008 | CA2673717A1 Method for administration of pegylated liposomal doxorubicin |
| 06/26/2008 | CA2673419A1 Pharmaceutical composition |
| 06/26/2008 | CA2673418A1 Pharmaceutical compound and composition |
| 06/26/2008 | CA2673337A1 Bone growth particles and osteoinductive composition thereof |
| 06/26/2008 | CA2673193A1 Homogeneous paste and gel formulations |
| 06/26/2008 | CA2672973A1 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | CA2672810A1 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | CA2672618A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | CA2672598A1 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 06/26/2008 | CA2672400A1 Gelatin capsules comprising an acid |
| 06/26/2008 | CA2672284A1 Human growth hormone formulations |
| 06/26/2008 | CA2672262A1 Radioactive diagnostic imaging agent |
| 06/26/2008 | CA2671728A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | CA2671727A1 A composition containing a bisphosphonic acid in combination with vitamin d |
| 06/26/2008 | CA2671670A1 Sustained-release composition and method for producing the same |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/26/2008 | CA2670453A1 Dispersion of polyamino acids in a continuous lipid phase |
| 06/26/2008 | CA2665762A1 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/25/2008 | EP1935431A2 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 06/25/2008 | EP1935422A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid |
| 06/25/2008 | EP1935421A1 Controlled-release compositions containing opioid agonist and antagonist |
| 06/25/2008 | EP1935415A2 Treatment of androgen-deprivation induced osteoporosis |
| 06/25/2008 | EP1935413A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 06/25/2008 | EP1935412A2 Pharmaceutical composition containing 5-chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidine-4-yl]-1,3-dihydro-2H-benzimidazol-2-one and method of preparing same |
| 06/25/2008 | EP1935411A1 Slow release excipient and its use |
| 06/25/2008 | EP1935410A1 Microcapsules |
| 06/25/2008 | EP1935409A2 Synthetic platelets |
| 06/25/2008 | EP1935408A1 Device for the topical application of medical ozone for the treatment of oral cavity diseases |
| 06/25/2008 | EP1935407A1 Low viscosity liquid dosage forms |
| 06/25/2008 | EP1935406A1 Dispersible pharmaceutical formulations containing fluoxetine |
| 06/25/2008 | EP1935405A1 Orally disintegrating tablets |
| 06/25/2008 | EP1935252A1 Chewing gum composition |
| 06/25/2008 | EP1934138A2 Amphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 06/25/2008 | EP1933876A1 Particulate lipid pharmaceutical composition |
| 06/25/2008 | EP1933867A1 Solid vaccine formulation |
| 06/25/2008 | EP1933862A2 Methods and compositions for oral administration of proteins |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933837A2 Liquid pharmaceutical compositions of nimodipine |
| 06/25/2008 | EP1933827A2 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 06/25/2008 | EP1933816A1 Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use for the manufacture of a medicament |
| 06/25/2008 | EP1933815A2 Pharmaceutical packaging of an oral dosage combination |
| 06/25/2008 | EP1933814A2 Nanoparticulate aripiprazole formulations |
| 06/25/2008 | EP1933813A2 Sphingomyelin liposomes for the treatment of hyperactive bladder disorders |
| 06/25/2008 | EP1933812A1 Liposomes loaded with fullerene and process for their preparation |
| 06/25/2008 | EP1933811A2 Banded controlled release nanoparticle active agent formulation dosage forms and methods |
| 06/25/2008 | EP1933810A2 Intravesical drug delivery device and method |